AGP Executive Report
Last update: 7 hours agoFDA Approval: The FDA has approved Revolution Medicines’ daraxonrasib (Rasonque), a daily pill targeting KRAS-mutant metastatic pancreatic cancer, after a phase 3 trial showed overall survival nearly doubling to 13.2 months; Chicago Link: seven patients were treated in Chicago through City of Hope Cancer Center under a compassionate-use pathway; Quantum Funding: the NSF awarded CU Boulder $37.5M to expand quantum research, including atomic clocks and biomedical breath sensors; Quantum Hardware Push: Diraq published a roadmap arguing silicon spin qubits made with CMOS tech could scale to millions of qubits; Illinois Policy Tech: Gov. JB Pritzker signed a law setting statewide rules for e-bikes and scooters, including age limits, speed caps, and where they can be ridden starting Jan. 1; AI for Public Records: Veritone added AI-powered document redaction to help agencies handle FOIA releases faster while keeping human review in the loop.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
